Key Details
Price
$7.22Annual ROE
-91.35%Beta
0.75Events Calendar
Next earnings date:
Mar 04, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Mar 04, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Apr 12, 2023Analyst ratings
Recent major analysts updates
22 Aug '22 Chardan Capital
Buy17 May '22 Chardan Capital
Buy10 May '22 JMP Securities
Market Outperform03 Feb '22 William Blair
Market Perform02 Feb '22 Chardan Capital
Hold23 Dec '21 Chardan Capital
Buy17 Nov '21 Barclays
Overweight16 Nov '21 JMP Securities
Market Outperform07 June '21 HC Wainwright & Co.
Buy04 Mar '21 JMP Securities
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
LogicBio Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
FAQ
- What is the primary business of LogicBio Therapeutics?
- What is the ticker symbol for LogicBio Therapeutics?
- Does LogicBio Therapeutics pay dividends?
- What sector is LogicBio Therapeutics in?
- What industry is LogicBio Therapeutics in?
- What country is LogicBio Therapeutics based in?
- When did LogicBio Therapeutics go public?
- Is LogicBio Therapeutics in the S&P 500?
- Is LogicBio Therapeutics in the NASDAQ 100?
- Is LogicBio Therapeutics in the Dow Jones?
- When was LogicBio Therapeutics's last earnings report?
- When does LogicBio Therapeutics report earnings?
- Should I buy LogicBio Therapeutics stock now?
What is the primary business of LogicBio Therapeutics?
LogicBio Therapeutics (LOGC) is a biotechnology company focused on developing gene therapies for genetic disorders. They use innovative technologies to deliver genetic material to cells, aiming to treat conditions like methylmalonic acidemia and other rare diseases, improving patients' lives through advanced medical solutions.
What is the ticker symbol for LogicBio Therapeutics?
The ticker symbol for LogicBio Therapeutics is NASDAQ:LOGC
Does LogicBio Therapeutics pay dividends?
No, LogicBio Therapeutics does not pay dividends
What sector is LogicBio Therapeutics in?
LogicBio Therapeutics is in the Consumer Cyclical sector
What industry is LogicBio Therapeutics in?
LogicBio Therapeutics is in the Internet Retail industry
What country is LogicBio Therapeutics based in?
LogicBio Therapeutics is headquartered in United States
When did LogicBio Therapeutics go public?
LogicBio Therapeutics's initial public offering (IPO) was on 19 October 2018
Is LogicBio Therapeutics in the S&P 500?
No, LogicBio Therapeutics is not included in the S&P 500 index
Is LogicBio Therapeutics in the NASDAQ 100?
No, LogicBio Therapeutics is not included in the NASDAQ 100 index
Is LogicBio Therapeutics in the Dow Jones?
No, LogicBio Therapeutics is not included in the Dow Jones index
When was LogicBio Therapeutics's last earnings report?
LogicBio Therapeutics's most recent earnings report was on 7 November 2024
When does LogicBio Therapeutics report earnings?
The next expected earnings date for LogicBio Therapeutics is 4 March 2025
Should I buy LogicBio Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions